The Beroukhim laboratory performed a systematic exploration of potential therapeutic vulnerabilities deriving from loss of heterozygosity in cancer. Nature Communications, May 2020. Caitlin Nichols, who led the study, gave a great presentation on it as a Harvard Horizons Fellow.
Developing computational approaches to interpret cancer genomes | Comprehensive genomic characterization of brain cancers
